NEWS & EVENTS
PRESS RELEASES 2007
ELUSYS THERAPEUTICS TO PRESENT AT THE 9TH ANNUAL BIO CEO & INVESTOR CONFERENCE
Pine Brook, NJ – February 5, 2007 – Elusys Therapeutics, Inc., a biotechnology company developing targeted anti-infective antibodies to fight life-threatening infections, today announced that Elizabeth G. Posillico, Ph.D., President and Chief Executive Officer, will present at the 9th Annual BIO CEO & Investor Conference which will be held at The Waldorf-Astoria Hotel in New York City from February 12-14, 2007.
Dr. Posillico will present on February 14th at 3:00 PM in the Duke of Windsor room and will be available for one-on-one meetings during the conference. For more information about the 9th Annual BIO CEO & Investor Conference please visit http://ceo.bio.org/opencms/ceo/2007.
About Elusys
Elusys Therapeutics is a privately-held biopharmaceutical company focused on the development of targeted anti-infective therapeutics using its proprietary HP Antibodies™ for the treatment of lifethreatening infectious diseases. Current venture investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures, MedImmune Ventures and Pfizer. For more information on Elusys, please visit www.elusys.com.